Hangzhou AGS Medtech Co Ltd
688581
Company Profile
Business description
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
Contact
No. 389 Xingzhong Road
Linping District
Zhejiang Province
Hangzhou311199
CHNT: +86 57188775216
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
744
Stocks News & Analysis
stocks
This might be the best core stock bargain in the US market today
Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks
Data center demand drives strong earnings outlook for SGM
Sims guides huge earnings upgrade as data center metals demand spikes.
stocks
Chart of the Week: AI proving a threat to company moats
The latest insights on AI from our equity research team.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,646.50 | 16.60 | -0.19% |
| CAC 40 | 7,807.87 | 162.01 | -2.03% |
| DAX 40 | 22,839.56 | 662.69 | -2.82% |
| Dow JONES (US) | 46,021.43 | 203.72 | -0.44% |
| FTSE 100 | 10,063.50 | 241.79 | -2.35% |
| HKSE | 25,500.58 | 524.84 | -2.02% |
| NASDAQ | 22,090.69 | 61.73 | -0.28% |
| Nikkei 225 | 53,372.53 | 1,866.87 | -3.38% |
| NZX 50 Index | 12,974.74 | 76.87 | -0.59% |
| S&P 500 | 6,606.49 | 18.21 | -0.27% |
| S&P/ASX 200 | 8,456.40 | 15.90 | -0.19% |
| SSE Composite Index | 4,006.55 | 0.00 | 0.00% |